On 15/10/2018 ESE announces:"Life science company eSense-Lab Ltd...

On 15/10/2018 ESE announces:

"Life science company eSense-Lab Ltd ("eSense" or the "Company") (ASX:ESE) is pleased to announce thatit has received confirmation of binding commitments for 105,000,000 Chess Depositary Interest (“CDIs”) at ashare price of AUD $0.03, for proceeds of AUD $3.15 million before costs (“Placement”)."

20m given away to friends and cronies under Company's placement capacities

85m (+35m free-attaching options) to be approved at the AGM

On 16/10/2018 ESE announces:

"continuation of their commercialisation activities with the supply of their material to the UK market ... purchased in the aggregate of seven (7) liters of eSense’s SuperLemon Haze strain ... [by a] UK basedcompany (who at present will not be named)"

Given how close the two announcement were given to the market, it would be reasonable to assume the facts were know tho the management. Why, then give away so large amount of shares at a record breaking low price of 3c?  This amounts to defrauding the current shareholders. The order of these announcements should be investigated by ASX.

I hope there will be enough votes to strike to proposal at the AGM, however the share register and the 20m already awarded would most likely push the numbers in directors favour to the detriment of current holders.